Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps his Department is taking to support the rollout of new medicines developed in the UK to tackle malaria.

British science was key to the development of the first two vaccines ever to be recommended for use by WHO to prevent malaria. The UK's £1.65 billion funding to Gavi is also helping to fund the rollout of malaria vaccines and will immunise more than 6 million children by the end of 2025. Our funding to the Medicines for Malaria Venture (MMV), in partnership with more than 40 UK organisations including GSK and the University of Dundee, is developing a new generation of antimalarial medicines to address the emerging threat posed by drug resistance.